Table 2.
RAS-group | OS-group | P | |
---|---|---|---|
Mean operative time, min (range) | 245.6±92.4 (110–495) | 267.8±69.0 (135–415) | 0.32 |
Spleen preserving, n (%) | 17 (63) | 9 (33.3) | <0.05 |
Conversion to laparoscopic/open approach, n (%) | 0 | ||
Intraoperative complications, n (%) | 0 | 0 | 1 |
Estimate blood loss, ml (range) | 179 (100–250) | 204 (100–300) | 0.05 |
Median hospital stay, days (range) | 8 (3–25) | 12 (7–26) | <0.01 |
2016 ISGPS POPF, n (%) | 3 (11.1) | 3 (11.1) | 1 |
Biochemical leak | 7 (25.9) | 8 (29.6) | 0.76 |
Grade B POPF | 3 (11.1) | 3 (11.1) | 1 |
Grade C POPF | 0 | 0 | 1 |
Intra-abdominal collection, n (%) | 8 (29.6) | 5 (18.5) | 0.34 |
Medical complications, n (%) | 2 (7.4) | 3 (11.1) | 0.64 |
Clavien-Dindo Grade I | 0 | 1 (3.7) | 0.31 |
Clavien-Dindo Grade II | 2 (7.4) | 2 (7.4) | 1 |
Post-operative mellitus diabetes, n (%) | 5 (18.5) | 5 (18.5) | 1 |
Reoperation, n (%) | 0 | 1 (3.7) | 0.31 |
Mortality, n (%) | 0 | 0 | 1 |
POPF: Post-operative pancreatic fistula, ISGPS: International Study Group on Pancreatic Surgery, OS: Open surgery, RAS: Robotic-assisted surgery